{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:00:19Z","timestamp":1785517219418,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["1919B012468434"],"award-info":[{"award-number":["1919B012468434"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12477-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:36:59Z","timestamp":1785310619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin D delivered through carbon quantum dots modifies cytokine expression and migration in MCF-7 breast cancer cells"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-9137","authenticated-orcid":false,"given":"Lutfiye Karcioglu","family":"Batur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuneyd","family":"Yavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firuze","family":"Kulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buse","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsen","family":"Pektas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besa","family":"Bilakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Akcali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif Sibel","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"Gunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail Tuncer","family":"Degim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"12477_CR1","doi-asserted-by":"crossref","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, Fidler-Benaoudia MM (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31(4):1154\u20131162","DOI":"10.1038\/s41591-025-03502-3"},{"issue":"S1","key":"12477_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1634\/theoncologist.2011-S1-61","volume":"16","author":"CM Perou","year":"2011","unstructured":"Perou CM (2011) Molecular stratification of triple-negative breast cancers. Oncologist 16(S1):61\u201370","journal-title":"Oncologist"},{"key":"12477_CR3","doi-asserted-by":"crossref","unstructured":"Perou CM Phadke, S., Miller, K. D., Shah, A., Danciu, O. C., Chen, Y., Yu, M., \u2026 Wisinski,K. B. (2025). Phase I\/II trial investigating gedatolisib plus talazoparib in advanced triple negative or BRCA1\/2 positive, HER2 negative breast cancers. Breast cancer research and treatment 1\u201310","DOI":"10.1007\/s10549-025-07747-x"},{"issue":"1","key":"12477_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","volume":"16","author":"A Zafar","year":"2025","unstructured":"Zafar A, Khatoon S, Khan MJ, Abu J, Naeem A (2025) Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discover Oncol 16(1):607","journal-title":"Discover Oncol"},{"key":"12477_CR5","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics. CA: a cancer journal for clinicians 72(1):7\u201333","DOI":"10.3322\/caac.21708"},{"issue":"2","key":"12477_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/carcin\/bgp289","volume":"31","author":"R Behera","year":"2010","unstructured":"Behera R, Kumar V, Lohite K, Karnik S, Kundu GC (2010) Activation of JAK2\/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 31(2):192\u2013200","journal-title":"Carcinogenesis"},{"issue":"4","key":"12477_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR (2018) Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat reviews Clin Oncol 15(4):234\u2013248","journal-title":"Nat reviews Clin Oncol"},{"issue":"2","key":"12477_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12026-011-8262-6","volume":"51","author":"T Sato","year":"2011","unstructured":"Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo MJ, Selvan SR (2011) Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res 51(2):170\u2013182","journal-title":"Immunol Res"},{"issue":"3","key":"12477_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11914-022-00732-z","volume":"20","author":"DD Bikle","year":"2022","unstructured":"Bikle DD (2022) Vitamin D regulation of immune function. Curr Osteoporos Rep 20(3):186\u2013193","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"12477_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1017\/S0954422407742713","volume":"20","author":"F Baeke","year":"2007","unstructured":"Baeke F, Van Etten E, Overbergh L, Mathieu C (2007) Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutr Res Rev 20(1):106\u2013118","journal-title":"Nutr Res Rev"},{"issue":"1","key":"12477_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s10753-012-9531-9","volume":"36","author":"Z Jamali","year":"2013","unstructured":"Jamali Z, Arababadi MK, Asadikaram G (2013) Serum levels of IL-6, IL-10, IL-12, IL-17 and IFN-\u03b3 and their association with markers of bone metabolism in vitamin D-deficient female students. Inflammation 36(1):164\u2013168","journal-title":"Inflammation"},{"issue":"1","key":"12477_CR12","doi-asserted-by":"publisher","first-page":"24225","DOI":"10.1038\/s41598-024-73737-6","volume":"14","author":"AS Syed Khaja","year":"2024","unstructured":"Syed Khaja AS, Binsaleh NK, Beg MM et al (2024) Clinical importance of cytokine (IL-6, IL-8, and IL-10) and vitamin D levels among patients with Type-1 diabetes. Sci Rep 14(1):24225","journal-title":"Sci Rep"},{"issue":"11","key":"12477_CR13","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1096\/fj.12-210880","volume":"26","author":"SJ Mutt","year":"2012","unstructured":"Mutt SJ, Karhu T, Lehtonen S et al (2012) Inhibition of cytokine secretion from adipocytes by 1, 25\u2010dihydroxyvitamin D3 via the NF\u2010\u03baB pathway. FASEB J 26(11):4400\u20134407","journal-title":"FASEB J"},{"issue":"9","key":"12477_CR14","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/10408398.2012.688897","volume":"55","author":"P Borel","year":"2015","unstructured":"Borel P, Caillaud D, Cano NJ (2015) Vitamin D bioavailability: state of the art. Crit Rev Food Sci Nutr 55(9):1193\u20131205","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"12","key":"12477_CR15","doi-asserted-by":"publisher","first-page":"2200299","DOI":"10.1002\/ardp.202200299","volume":"355","author":"S Singh","year":"2022","unstructured":"Singh S, Raina D, Rishipathak D et al (2022) Quantum dots in the biomedical world: A smart advanced nanocarrier for multiple venues application. Arch Pharm 355(12):2200299","journal-title":"Arch Pharm"},{"issue":"1","key":"12477_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s11671-016-1394-9","volume":"11","author":"MX Zhao","year":"2016","unstructured":"Zhao MX, Zhu BJ (2016) The research and applications of carbon quantum dots as nano-carriers for targeted drug delivery and cancer therapy. Nanoscale Res Lett 11(1):207","journal-title":"Nanoscale Res Lett"},{"key":"12477_CR17","doi-asserted-by":"crossref","unstructured":"Zhao MX, Zhu BJ Kumar, M., Chinnathambi, S., Bakhori, N., Abu, N., Etezadi, F., Thangavel, V., \u2026 Pandian,G. N. (2024). Biomass-derived carbon dots as fluorescent quantum probes to visualize and modulate inflammation. Scientific Reports, 14(1), 12665","DOI":"10.1038\/s41598-024-62901-7"},{"key":"12477_CR18","doi-asserted-by":"publisher","unstructured":"Soule HD, Vazquez J, Long A, Albert S, Brennan MJ J. O. T. N. C. I. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst, 51(5), 1409\u20131416. https:\/\/doi.org\/10.1093\/jnci\/51.5.1409","DOI":"10.1093\/jnci\/51.5.1409"},{"issue":"5","key":"12477_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/cimb47050364","volume":"47","author":"L Karcioglu Batur","year":"2025","unstructured":"Karcioglu Batur L, Yavas C, Hekim N (2025) Kiperin double-hydrolyzed collagen as a potential anti-tumor agent: Effects on HCT116 colon carcinoma cells and oxidative stress modulation. Curr Issues Mol Biol 47(5):364. https:\/\/doi.org\/10.3390\/cimb47050364","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"12477_CR20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/biomedicines13061430","volume":"13","author":"L Karcioglu Batur","year":"2025","unstructured":"Karcioglu Batur L, Yavas C, Ekeno\u011flu Merdan Y, Aygan A (2025) Kiperin postbiotic supplement-enhanced bacterial supernatants promote fibroblast function: Implications for regenerative medicine. Biomedicines 13(6):1430. https:\/\/doi.org\/10.3390\/biomedicines13061430","journal-title":"Biomedicines"},{"issue":"6","key":"12477_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/ph18060767","volume":"18","author":"G Camlik","year":"2025","unstructured":"Camlik G, Bilakaya B, G\u00fcven GK, Akkol EK, Degim Z, Sobarzo-S\u00e1nchez E, Degim IT (2025) Quantum drugs (Q-Drugs): a new discovery and taboo breaking approach; producing carbon quantum dots from drug molecules. Pharmaceuticals 18(6):767","journal-title":"Pharmaceuticals"},{"issue":"4","key":"12477_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2009\u2013 \u2206\u2206CT method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"issue":"8","key":"12477_CR23","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/nano12081376","volume":"12","author":"A Crintea","year":"2022","unstructured":"Crintea A, Dutu AG, Sovrea A, Constantin AM, Samasca G, Masalar AL, Craciun AM (2022) Nanocarriers for drug delivery: an overview with emphasis on vitamin D and K transportation. Nanomaterials 12(8):1376","journal-title":"Nanomaterials"},{"issue":"9","key":"12477_CR24","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/biom14091090","volume":"14","author":"I Aggeletopoulou","year":"2024","unstructured":"Aggeletopoulou I, Kalafateli M, Geramoutsos G, Triantos C (2024) Recent advances in the use of vitamin D organic nanocarriers for drug delivery. Biomolecules 14(9):1090","journal-title":"Biomolecules"},{"issue":"1","key":"12477_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1208\/s12249-018-1231-9","volume":"20","author":"R Gupta","year":"2018","unstructured":"Gupta R, Behera C, Paudwal G, Rawat N, Baldi A, Gupta PN (2018) Recent advances in formulation strategies for efficient delivery of vitamin D. AAPS PharmSciTech 20(1):11","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"12477_CR26","doi-asserted-by":"publisher","first-page":"6213872","DOI":"10.1155\/2016\/6213872","volume":"2016","author":"MJ Larriba","year":"2016","unstructured":"Larriba MJ, Garc\u00eda de Herreros A, Mu\u00f1oz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem cells Int 2016(1):6213872","journal-title":"Stem cells Int"},{"issue":"7","key":"12477_CR27","doi-asserted-by":"publisher","first-page":"bqab049","DOI":"10.1210\/endocr\/bqab049","volume":"162","author":"J Li","year":"2021","unstructured":"Li J, Luco AL, Camirand A, St-Arnaud R, Kremer R (2021) Vitamin D regulates CXCL12\/CXCR4 and epithelial-to-mesenchymal transition in a model of breast cancer metastasis to lung. Endocrinology 162(7):bqab049","journal-title":"Endocrinology"},{"issue":"2","key":"12477_CR28","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/ERC-21-0182","volume":"29","author":"J Vanhevel","year":"2022","unstructured":"Vanhevel J, Verlinden L, Doms S, Wildiers H, Verstuyf A (2022) The role of vitamin D in breast cancer risk and progression. Endocrine-related Cancer 29(2):R33\u2013R55","journal-title":"Endocrine-related Cancer"},{"issue":"3","key":"12477_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/2326-6066.CIR-13-0214","volume":"2","author":"M Oft","year":"2014","unstructured":"Oft M (2014) IL-10: master switch from tumor-promoting inflammation to antitumor immunity. Cancer Immunol Res 2(3):194\u2013199","journal-title":"Cancer Immunol Res"},{"key":"12477_CR30","doi-asserted-by":"publisher","first-page":"205031212110690","DOI":"10.1177\/20503121211069012","volume":"10","author":"B Mirlekar","year":"2022","unstructured":"Mirlekar B (2022) Tumor promoting roles of IL-10, TGF-\u03b2, IL-4, and IL-35: Its implications in cancer immunotherapy. SAGE open Med 10:20503121211069012","journal-title":"SAGE open Med"},{"key":"12477_CR31","doi-asserted-by":"crossref","unstructured":"Mirlekar B Batchu, R. B., Gruzdyn, O. V., Kolli, B. K., Dachepalli, R., Umar, P. S., Rai, S.K., \u2026 Gruber, S. A. (2021). IL-10 signaling in the tumor microenvironment of ovarian cancer. Tumor Microenvironment: The Role of Interleukins\u2013Part B, 51\u201365","DOI":"10.1007\/978-3-030-55617-4_3"},{"key":"12477_CR32","doi-asserted-by":"crossref","unstructured":"Yetkin D, Ball\u0131 E, Bayrak G, Kibar D, T\u00fcrkeg\u00fcn M (2018), December The investigation of the effects of tamoxifen and vitamin D combination on the expression of P53, Bcl-2 and bax and cell cycle in MCF-7 cell line. In Proceedings (Vol. 2, No. 25, p. 1527). MDPI","DOI":"10.3390\/proceedings2251527"},{"key":"12477_CR33","doi-asserted-by":"crossref","unstructured":"Yetkin D, Ball\u0131 E, Bayrak G, Kibar D, T\u00fcrkeg\u00fcn M Alamro, A. A., Al-Malky, M. M., Ansari, M. G., Amer, O. E., Alnaami, A. M., Hussain,S. D., \u2026 Al-Daghri, N. M. (2021). The effects of melatonin and vitamin D3 on the gene expression of BCl-2 and BAX in MCF-7 breast cancer cell line. Journal of King Saud University-Science, 33(2), 101287","DOI":"10.1016\/j.jksus.2020.101287"},{"issue":"19","key":"12477_CR34","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.3390\/cancers15194833","volume":"15","author":"PKM Veeresh","year":"2023","unstructured":"Veeresh PKM, Basavaraju CG, Dallavalasa S, Anantharaju PG, Natraj SM, Sukocheva OA, Madhunapantula SV (2023) Vitamin D3 inhibits the viability of breast cancer cells in vitro and ehrlich ascites carcinomas in mice by promoting apoptosis and cell cycle arrest and by impeding tumor angiogenesis. Cancers 15(19):4833","journal-title":"Cancers"},{"issue":"1\u20132","key":"12477_CR35","first-page":"111","volume":"71","author":"K Towsend","year":"2007","unstructured":"Towsend K, Trevino V, Falciani F, Stewart PM, Hewison M, Campbell MJ (2007) Identification of VDR-responsive gene signatures in breast cancer cells. Oncology 71(1\u20132):111\u2013123","journal-title":"Oncology"},{"issue":"1","key":"12477_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13058-019-1169-1","volume":"21","author":"L Huss","year":"2019","unstructured":"Huss L, Butt ST, Borgquist S, Elebro K, Sandsveden M, Rosendahl A, Manjer J (2019) Vitamin D receptor expression in invasive breast tumors and breast cancer survival. Breast Cancer Res 21(1):84","journal-title":"Breast Cancer Res"},{"key":"12477_CR37","doi-asserted-by":"crossref","unstructured":"Huss L, Butt ST, Borgquist S, Elebro K, Sandsveden M, Rosendahl A, Manjer J Nam, S. E., Jin, T., Park, K. S., Saindane, M., Noh, W. C., Yoo, Y. B., \u2026 Yun, I.J. (2022). Vitamin D receptor (VDR) mRNA overexpression is associated with poor prognosis in breast carcinoma. Annals of Surgical Treatment and Research, 103(4), 183\u2013194","DOI":"10.4174\/astr.2022.103.4.183"},{"issue":"1","key":"12477_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.21673\/anadoluklin.987578","volume":"27","author":"L Karc\u0131o\u011flu","year":"2022","unstructured":"Karc\u0131o\u011flu L (2022) Correlation of the variations in prevalence of coronavirus disease 2019 and vitamin D receptor gene polymorphisms in cohorts from 26 countries. Anatol Clin J Med Sci 27(1):60\u201370. https:\/\/doi.org\/10.21673\/anadoluklin.987578","journal-title":"Anatol Clin J Med Sci"},{"key":"12477_CR39","doi-asserted-by":"publisher","unstructured":"Karc\u0131o\u011flu Batur L, Dokur M, Ko\u00e7 S, Karabay M, Akcay ZN, Gunger E, Hekim N (2024) Investigation of the relationship between vitamin D deficiency and vitamin D-binding protein polymorphisms in severe COVID-19 patients. Diagnostics, 14(17), 1941. https:\/\/doi.org\/10.3390\/diagnostics14171941","DOI":"10.3390\/diagnostics14171941"},{"key":"12477_CR40","doi-asserted-by":"crossref","unstructured":"Karc\u0131o\u011flu Batur L, Dokur M, Ko\u00e7 S, Karabay M, Akcay ZN, Gunger E, Hekim N Chiang, K. C., Yeh, C. N., Huang, C. C., Yeh, T. S., S. Pang, J. H., Hsu, J. T., \u2026Juang, H. H. (2016). 25 (OH) D is effective to repress human cholangiocarcinoma cell growth through the conversion of 25 (OH) D to 1\u03b1, 25 (OH) 2D3. International Journal of Molecular Sciences, 17(8), 1326. Doi: 10.3390\/ijms17081326","DOI":"10.3390\/ijms17081326"},{"key":"12477_CR41","doi-asserted-by":"publisher","unstructured":"Cross HS (2010) In: Vitamin D, Cancer (eds) Vitamin D: synthesis and catabolism\u2013considerations for cancer causation and therapy. Springer New York, New York, NY, pp 1\u201324. Doi: https:\/\/doi.org\/10.1007\/978-1-4419-7188-3","DOI":"10.1007\/978-1-4419-7188-3"},{"issue":"9","key":"12477_CR42","first-page":"3659","volume":"29","author":"M Seifert","year":"2009","unstructured":"Seifert M, Tilgen W, Reichrath J (2009) Expression of 25-hydroxyvitamin D-1\u03b1-hydroxylase (1\u03b1OHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. Anticancer Res 29(9):3659\u20133667","journal-title":"Anticancer Res"},{"issue":"1","key":"12477_CR43","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1038\/s41598-018-27441-x","volume":"8","author":"T Susa","year":"2018","unstructured":"Susa T, Iizuka M, Okinaga H, Tamamori-Adachi M, Okazaki T (2018) Without 1\u03b1-hydroxylation, the gene expression profile of 25 (OH) D3 treatment overlaps deeply with that of 1, 25 (OH) 2D3 in prostate cancer cells. Sci Rep 8(1):9024. https:\/\/doi.org\/10.1038\/s41598-018-27441-x","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12477-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12477-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12477-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:07:57Z","timestamp":1785514077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12477-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12477"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12477-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest related to this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Scientific Researches Ethical Committee of Biruni University on 20 January 2025 with the decree number 2024-BIAEK\/06\u201347. All procedures were conducted in accordance with international ethical research guidelines and institutional policies.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not involve any human participants, human data, or tissue.","order":3,"name":"Ethics","label":"Patient consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1296"}}